Business Combination (Details) - Advent BioServices € in Millions, £ in Millions, shares in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
|
Oct. 24, 2025
USD ($)
shares
|
Oct. 24, 2025
GBP (£)
shares
|
Oct. 24, 2025
EUR (€)
shares
|
Oct. 24, 2024
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| Business Combination | |||||
| Payment term for consideration | 2 years | 2 years | 2 years | ||
| Total consideration | $ 1,864,000 | £ 1.4 | |||
| Amount of bargain purchase | 35,400,000 | ||||
| Liabilities incurred | 6,000,000 | $ 6,000,000 | |||
| Aggregate accounts payable of acquiree | 8,300,000 | ||||
| Liabilities assumed by the acquirer | 2,300,000 | € 2.3 | 2,300,000 | ||
| Remaining accounts payable | $ 700,000 | $ 700,000 | |||
| Unpaid balance, accrue interest rate | 7.50% | 7.50% | 7.50% | ||
| Number of shares reacquired | shares | 12.0 | 12.0 | 12.0 | ||
| Number of options reacquired | shares | 5.5 | 5.5 | 5.5 | ||
| Transaction expense | $ 85,000 | ||||
| X | ||||||||||
- Definition Amount of accounts payable excluded from the business combination transaction. No definition available.
|
| X | ||||||||||
- Definition Amount of aggregate accounts payable of acquiree from the business combination transaction. No definition available.
|
| X | ||||||||||
- Definition In a business combination in which the amount of bargain purchase gain on recognized excluding hypothetical deferred tax liabilities. No definition available.
|
| X | ||||||||||
- Definition Period during which the company is required to make consideration for business acquisition, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of liabilities assumed by the acquirer as part of consideration transferred in a business combination. No definition available.
|
| X | ||||||||||
- Definition Total number of company's options reverted back at the time of acquisition which were issued earlier for contract services. No definition available.
|
| X | ||||||||||
- Definition Total number of company's shares reverted back at the time of acquisition which were issued earlier for contract services. No definition available.
|
| X | ||||||||||
- Definition Percentage of stated interest rate on the unpaid accounts payable balance pursuant to business combination No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|